Carrier-free Arg-CpG augments antitumor efficacy by triggering specific immune activation
The delivery of nucleic acids using nonviral vectors represents a promising approach for cancer therapy. Nevertheless, nucleic acid–based drugs suffer from poor potency and rapid degradation. Herein, we report a carrier-free nucleic acid delivery system ...